Short Summary:
Regenerative medicine is no longer science fiction. In this deep-dive episode, Adeel Khan, MD a leader in cell therapy innovation, joins Alexia Brue to explore the science behind stem cells, gene editing, and tissue engineering. From MSCs and exosomes to the ethics of access and experimentation, Dr. Khan unpacks both the promise and the hype around the most futuristic corner of the longevity movement.

This episode also features insights from Beth McGroarty, VP of Research & Forecasting at the Global Wellness Institute, who shares her thoughts on regenerative medicine, and whether the wellness industry is ready for this level of science and the potential culture/knowledge gap that’s happening.

Inside this episode:

• What regenerative medicine means—and how it differs from functional medicine
• Why stem cells from your own body may not be the best bet after age 40
• The future of gene editing: CRISPR, prime editing, and cellular repair
• Autologous vs. allogeneic therapies: what's scalable, what's safe
• Equity concerns: how longevity tech could widen the health gap
• Global regulatory hurdles—and the need for new frameworks for safety and efficacy

Resources Mentioned:

• Dr. Adeel Khan’s Eterna Medicinal Practice
• Global Wellness Institute

Hosted by: Alexia Brue, co-founder of Well+Good; founder of a new healthspan training studio, The Practice; member of the Global Wellness Institute Board of Advisors

To learn more about the Global Wellness Institute please visit us at globalwellnessinstitute.org, connect with us on Instagram and subscribe to our YouTube channel.

Produced by: Emily Roberts and Ali Alquiza of Over Lunch

Music provided by: Myndstream

Thank you to our sponsor, Fountain Life, for supporting the GWI Podcast. Head to FountainLife.com to learn more.

Subscribe, rate, & review wherever you listen to podcasts!